Cargando…
MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer
Dysregulated microRNAs (miRNAs) have been implicated in the pathogenic processes of colon cancer. Epithelial mesenchymal transition (EMT) promotes metastatic progression and cancer stem cells are closely involved in colon cancer proliferation and metastasis. Functional effects of miR-377 on colon ca...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588759/ https://www.ncbi.nlm.nih.gov/pubmed/33084522 http://dx.doi.org/10.1177/1533033820967475 |
_version_ | 1783600430916304896 |
---|---|
author | Shayimu, Paerhati Yusufu, Aikeremu Rehemutula, Aizimaiti Redati, Darebai Jiapaer, Rexida Tuerdi, Rousidan |
author_facet | Shayimu, Paerhati Yusufu, Aikeremu Rehemutula, Aizimaiti Redati, Darebai Jiapaer, Rexida Tuerdi, Rousidan |
author_sort | Shayimu, Paerhati |
collection | PubMed |
description | Dysregulated microRNAs (miRNAs) have been implicated in the pathogenic processes of colon cancer. Epithelial mesenchymal transition (EMT) promotes metastatic progression and cancer stem cells are closely involved in colon cancer proliferation and metastasis. Functional effects of miR-377 on colon cancer stem cell phenotypes and EMT were then determined in the present study. Firstly, reduced miR-377 was found in colon cancer tissues and cell lines. Results from flow cytometry, sphere formation and western blot assays showed that miR-377 knockdown increased number of ALDH+ cells and promoted sphere formation ability. Moreover, cell migration/invasion and EMT of colon cancer cells were suppressed by miR-377 over-expression. On the contrary, miR-377 mimics caused the reversed results. ZEB2 (zinc finger E box-binding homeobox 2) was then validated as a binding target of miR-377. ZEB2 over-expression reversed the inhibitory abilities of miR-377 on cancer stem cell phenotypes, EMT, migration and invasion. In conclusion, miR-377 regulates cancer stem cell phenotypes and EMT in colon cancer cells via regulation of ZEB2, suggesting a new therapeutic strategy for colon cancer treatment. |
format | Online Article Text |
id | pubmed-7588759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-75887592020-11-09 MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer Shayimu, Paerhati Yusufu, Aikeremu Rehemutula, Aizimaiti Redati, Darebai Jiapaer, Rexida Tuerdi, Rousidan Technol Cancer Res Treat Original Article Dysregulated microRNAs (miRNAs) have been implicated in the pathogenic processes of colon cancer. Epithelial mesenchymal transition (EMT) promotes metastatic progression and cancer stem cells are closely involved in colon cancer proliferation and metastasis. Functional effects of miR-377 on colon cancer stem cell phenotypes and EMT were then determined in the present study. Firstly, reduced miR-377 was found in colon cancer tissues and cell lines. Results from flow cytometry, sphere formation and western blot assays showed that miR-377 knockdown increased number of ALDH+ cells and promoted sphere formation ability. Moreover, cell migration/invasion and EMT of colon cancer cells were suppressed by miR-377 over-expression. On the contrary, miR-377 mimics caused the reversed results. ZEB2 (zinc finger E box-binding homeobox 2) was then validated as a binding target of miR-377. ZEB2 over-expression reversed the inhibitory abilities of miR-377 on cancer stem cell phenotypes, EMT, migration and invasion. In conclusion, miR-377 regulates cancer stem cell phenotypes and EMT in colon cancer cells via regulation of ZEB2, suggesting a new therapeutic strategy for colon cancer treatment. SAGE Publications 2020-10-21 /pmc/articles/PMC7588759/ /pubmed/33084522 http://dx.doi.org/10.1177/1533033820967475 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Shayimu, Paerhati Yusufu, Aikeremu Rehemutula, Aizimaiti Redati, Darebai Jiapaer, Rexida Tuerdi, Rousidan MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer |
title | MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and
Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon
Cancer |
title_full | MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and
Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon
Cancer |
title_fullStr | MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and
Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon
Cancer |
title_full_unstemmed | MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and
Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon
Cancer |
title_short | MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and
Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon
Cancer |
title_sort | microrna-377 counteracts with cancer stem cell phenotypes and
epithelial mesenchymal transformation by targeting zeb2 in colon
cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588759/ https://www.ncbi.nlm.nih.gov/pubmed/33084522 http://dx.doi.org/10.1177/1533033820967475 |
work_keys_str_mv | AT shayimupaerhati microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer AT yusufuaikeremu microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer AT rehemutulaaizimaiti microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer AT redatidarebai microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer AT jiapaerrexida microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer AT tuerdirousidan microrna377counteractswithcancerstemcellphenotypesandepithelialmesenchymaltransformationbytargetingzeb2incoloncancer |